$MDB

Why is MongoDB stock climbing today?

MongoDB (MDB) stock rises 1.8% in pre-market trading after a prior session sell-off, despite strong Q2 FY2027 results with $772M revenue (30% YoY growth) and raised full-year guidance. Analysts reaffirm positive ratings and price targets, citing raised Atlas growth outlook. Broader market is neutral, with peer GitLab's strong earnings providing support.

Original reporting
Published Sep 3, 2026, 10:05 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 3, 2026, 10:23 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$MDB
Bullish
high confidence
Mentioned
$MDB
Relevance
8/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$MDBBullishHigh
01

Why it matters

The earnings beat and raised guidance are likely to reverse the prior day's decline and attract buying interest.

02

Market read

The report provides fresh guidance that can shift short‑term price action for MDB and influence the enterprise software sector.

03

What to watch

Potential slowdown in Atlas growth after the upcoming investor day.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

MongoDB's earnings were released after a sharp sell‑off, with analysts reiterating bullish ratings.

Company-level read

Ticker impact

$MDBBullishHigh confidence
Context

MongoDB reported Q2 FY2027 results with $772M revenue (+30% YoY) and raised full-year guidance to $2.99B‑$3.03B.

Expected impact

Potential upside of 5‑10% over the next few days.

Evidence & confidence

Strong revenue growth and guidance raise expectations; analysts upgraded price targets.

Market effects

Enterprise software and database segment may see broader optimism.

U.S. tech sector gains modest support.

Limited to investors tracking cloud database providers.

Counterpoint

Guidance still below some high‑growth peers; valuation remains elevated.

Key entities

  • MongoDB

    Database software provider reporting Q2 FY2027 results.

Related articles

$MDBHighAI 9/10

MongoDB Q2 FY2027 earnings beat but stock falls on Atlas growth

MongoDB reported Q2 FY2027 revenue of $771.8M, up 30% YoY, and raised full-year guidance. Adjusted EPS was $1.90, beating estimates. Atlas cloud service revenue grew 29% YoY, but stock fell 14% premarket due to growth deceleration concerns. Profitability improved with non-GAAP operating margin at 24%.

$MDBMedAI 8/10

MongoDB, Inc. Q2 2027 Earnings Call Summary

MongoDB reported Q2 2027 revenue growth of 30%, with Enterprise Advanced (EA) up 36% due to new search capabilities. Atlas growth guidance raised to 27% and EA to 11%. The company added 2.9k net new customers, totaling 70.6k. Management expects full-year 'Rule of 44' performance with 23% revenue growth and 21% operating margin.

$MDBMedAI 8/10

Why MongoDB Fell This Week

MongoDB's (MDB) stock fell 14.5% this week despite strong Q2 results, with revenue up 30.5% to $771.8M and EPS up 90% to $1.90, both beating expectations. The company raised guidance, but investors were underwhelmed by slower growth in its Atlas segment, which now accounts for 73% of revenue. MongoDB trades at 59x EPS and 10x revenue estimates.

$MDBHighAI 9/10

MongoDB missed one number and investors punished the stock

MongoDB (MDB) beat revenue and profit estimates, with total revenue at $771.8M (up 30% YoY) and adjusted earnings at $1.90 per share. Atlas, its cloud platform, grew 28.9% YoY, missing some investors' 30% expectations. Despite raising full-year guidance, the stock fell 13.5% on Wednesday. Analysts maintained positive ratings, with price targets up to $560. CEO CJ Desai expects AI-driven growth to accelerate soon.

$MDBHighAI 8/10

Why MongoDB (MDB) Shares Are Plunging Today

MongoDB (MDB) shares fell 12.6% after Q2 2026 earnings beat estimates but missed AI growth expectations. Revenue was $771.8M vs $735.3M, EPS $1.90 vs $1.61. Atlas database growth remained at 29%, disappointing investors. The company raised FY 2027 guidance but emphasized prudence. Shares are down 5% YTD and 19.6% from 52-week high.